Khalil Saleh Selected Research

Khalil Saleh Research Topics

Disease

9	Neoplasms (Cancer) 07/2023 - 10/2017
5	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2018
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2021
3	Lymphoma (Lymphomas) 01/2023 - 03/2017
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2022 - 11/2018
2	Cholangiocarcinoma 12/2023 - 01/2023
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 04/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 09/2021
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 10/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 11/2019
2	Tumor Lysis Syndrome 01/2020 - 03/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Breast Neoplasms (Breast Cancer) 06/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Pathologic Complete Response 01/2023
1	Philadelphia Chromosome 01/2023
1	Splenomegaly 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 11/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Disease Progression 01/2018
1	Microsatellite Instability 01/2018
1	Infections 01/2018
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Fever (Fevers) 03/2017
1	Drug Hypersensitivity Syndrome 03/2017
1	Gout 03/2017
1	Myalgia 03/2017
1	Hypersensitivity (Allergy) 03/2017
1	Polymyositis 03/2017
1	Rhabdomyolysis 03/2017
1	Eosinophilia 03/2017

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2018
4	pembrolizumabIBA 01/2022 - 01/2018
2	futibatinibIBA 12/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
2	Rituximab (Mabthera)FDA Link 06/2022 - 01/2020
2	PlatinumIBA 01/2021 - 01/2018
1	Androgen Receptors (Androgen Receptor)IBA 02/2024
1	zolbetuximabIBA 01/2024
1	relatlimabIBA 07/2023
1	Bispecific AntibodiesIBA 06/2023
1	enfortumab vedotinIBA 06/2023
1	Monoclonal AntibodiesIBA 06/2023
1	Immunoconjugates (Immunoconjugate)IBA 06/2023
1	trastuzumab deruxtecanIBA 06/2023
1	sacituzumab govitecanIBA 06/2023
1	Ado-Trastuzumab EmtansineIBA 06/2023
1	axicabtagene ciloleucelIBA 01/2023
1	fedratinibIBA 01/2023
1	ruxolitinibIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Janus KinasesIBA 01/2023
1	AnthracyclinesIBA 06/2022
1	tazemetostatIBA 01/2022
1	cemiplimabIBA 07/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 11/2018
1	Etoposide (VP 16)FDA LinkGeneric 11/2018
1	Carmustine (FIVB)FDA Link 11/2018
1	InterferonsIBA 01/2018
1	Xanthine OxidaseIBA 03/2017
1	CreatinineIBA 03/2017
1	Febuxostat FDA Link 03/2017
1	Phosphotransferases (Kinase)IBA 03/2017
1	Etanercept (Enbrel)FDA Link 12/2016

Therapy/Procedure

10	Therapeutics 02/2024 - 01/2018
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
4	Immunotherapy 07/2023 - 01/2021
2	Stem Cell Transplantation 01/2023 - 11/2018
1	Precision Medicine 01/2023
1	Investigational Therapies (Experimental Therapy) 10/2021
1	Immunomodulation 01/2021
1	Radiotherapy 01/2020
1	Adjuvant Chemotherapy 09/2017